CH605725A5 - - Google Patents

Info

Publication number
CH605725A5
CH605725A5 CH1714573A CH1714573A CH605725A5 CH 605725 A5 CH605725 A5 CH 605725A5 CH 1714573 A CH1714573 A CH 1714573A CH 1714573 A CH1714573 A CH 1714573A CH 605725 A5 CH605725 A5 CH 605725A5
Authority
CH
Switzerland
Application number
CH1714573A
Inventor
Edward Douglas Brown
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH605725A5 publication Critical patent/CH605725A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/516Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Furan Compounds (AREA)
CH1714573A 1972-12-07 1973-12-06 CH605725A5 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5650172A GB1402035A (en) 1972-12-07 1972-12-07 Cyclopentane derivatives

Publications (1)

Publication Number Publication Date
CH605725A5 true CH605725A5 (ru) 1978-10-13

Family

ID=10476784

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1714573A CH605725A5 (ru) 1972-12-07 1973-12-06

Country Status (13)

Country Link
JP (1) JPS5024252A (ru)
AU (1) AU473283B2 (ru)
BE (1) BE808398A (ru)
CA (1) CA1016940A (ru)
CH (1) CH605725A5 (ru)
DE (1) DE2360893A1 (ru)
ES (1) ES421274A1 (ru)
FR (1) FR2209569B1 (ru)
GB (1) GB1402035A (ru)
IE (1) IE38515B1 (ru)
LU (1) LU68940A1 (ru)
NL (1) NL7316508A (ru)
ZA (1) ZA738797B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144459A1 (de) * 1983-12-09 1985-06-19 Dr. Willmar Schwabe GmbH & Co. Prostaglandine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
JPS6240987A (ja) * 1985-08-20 1987-02-21 Nippon Steel Corp レーザビーム溶接法
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Also Published As

Publication number Publication date
NL7316508A (ru) 1974-06-11
BE808398A (fr) 1974-06-07
AU473283B2 (en) 1976-06-17
IE38515B1 (en) 1978-03-29
FR2209569A1 (ru) 1974-07-05
IE38515L (en) 1974-06-07
ZA738797B (en) 1974-07-31
JPS5024252A (ru) 1975-03-15
AU6279773A (en) 1975-11-27
FR2209569B1 (ru) 1978-07-28
LU68940A1 (ru) 1974-02-12
CA1016940A (en) 1977-09-06
DE2360893A1 (de) 1974-06-12
GB1402035A (en) 1975-08-06
ES421274A1 (es) 1976-04-16

Similar Documents

Publication Publication Date Title
FR2209569B1 (ru)
JPS4927492U (ru)
CS151664B1 (ru)
CS152532B1 (ru)
CS152691B1 (ru)
CS152699B1 (ru)
CS152731B1 (ru)
CS153674B1 (ru)
CS153303B1 (ru)
CS153300B1 (ru)
CH566815A5 (ru)
CH567874A5 (ru)
BG17676A1 (ru)
BG20645A1 (ru)
CH1348472A4 (ru)
CH441173A4 (ru)
CH533572A4 (ru)
CH559489A5 (ru)
CH559550A5 (ru)
CH559783A5 (ru)
CH560410A (ru)
CH560765A5 (ru)
CH560870A5 (ru)
CH562334A5 (ru)
BG19955A1 (ru)

Legal Events

Date Code Title Description
PL Patent ceased